Stock
TAK US
TAKEDA PHARMACEUTIC-SP ADR · NYSE · USD · Healthcare
Heavy insider selling $13.1M (90d)
$18.86
+0.27 (+1.45%)
Price session: 2026-09-25 · Observed: 25 Sept 2026, 23:00 KSA · Source: delayed quote
Easy Score
70
Constructive
Value
—
no P/E stored — losses, no earnings yet, or fundamentals not fetched
Momentum
39
Trend
100
Partial score: the average of the engines that have data. Analysis, not financial advice.
Why is it moving?auto-generated
TAK +1.45% today · volume 1.2× average · no company-specific headlines in the stored feed.
Priceinteractive — your checked tools draw on it
Daily is the finest granularity · last ~6 months
RSI (14)
Patterns detected:
CloseMA 50MA 200check tools below to add them to the chart
Key technicals & risksame engine as the score
RSI (14)
60.2
MACD hist.
-0.02
50-day MA
$17.90
200-day MA
$17.07
ATR (14)
$0.28
Avg volume (20d)
2.3M
Volatility
21%
Max drawdown
-20%
Beta vs S&P
0.21
Daily plain-language briefs are a Pro feature.
Signal mix18
6
bullish
10
neutral
2
bearish
Every tool the engine can compute from stored bars. Check tools on the chart to see each one.
Street consensus21 analysts
Buy14
Hold7
Sell0
Forecast two independent reads
SystemYours · 2 toolsModel anchor (last stored close)
USD 18.53USD 19.21
USD 18.67USD 19.36
USD 18.86
USD 18.48USD 19.41
Computed from: USD 18.86 · session 2026-09-25 · 2509 historical windows
Lean score +0.43 — 1 bullish / 0 bearish / 1 neutral among your checked tools, weighted for this horizon. Your overlay is an exploratory scenario, not a calibrated prediction. The historical baseline stays unchanged. The system band is the 25th–75th percentile of this stock’s own historical moves for the horizon.
Technical indicators
Checked 2 of 2 allowed on Free plan
Sign in to save your tool selection per stock.
My notes on TAK private investment journal
Sign in to keep a dated journal per stock — your thesis lives next to the data.